Enzyme-pattern-targeted chemotherapy with tiazofurin and allopurinol in human leukemia
Tài liệu tham khảo
Weber, 1957, Glucose-6-phosphate utilization in hepatoma, regenerating and newborn rat liver, and in the liver of fed and fasted normal rats, Cancer Res., 17, 995
Weber, 1956, Liver glucose-6-phosphatase activity and intracellular distribution after cortisone administration, Endocrinology, 58, 40, 10.1210/endo-58-1-40
Weber, 1963, Behaviour and regulation of enzyme systems in normal liver and in hepatomas of different growth rates, Adv. Enzyme Regul., 1, 321, 10.1016/0065-2571(63)90028-1
Weber, 1983, Biochemical strategy of cancer cells and the design of chemotherapy: G.H.A. Clowes Memorial Lecture, Cancer Res., 43, 3466
Weber, 1985, Targets and markers of selective action of tiazofurin, Adv. Enzyme Regul., 24, 45, 10.1016/0065-2571(85)90069-X
Jackson, 1975, IMP dehydrogenase, an enzyme linked with proliferation and malignancy, Nature, 256, 331, 10.1038/256331a0
Becher, 1979, Inosine 5′-phosphate dehydrogenase in normal and leukemic blood cells, Klin. Wochenschr., 57, 1109, 10.1007/BF01481491
Jackson, 1980, Purine and pyrimidine nucleotide patterns of normal, differentiating, and regenerating liver and of hepatomas in rats, Cancer Res., 40, 1286
Natsumeda, 1988, De novo guanylate synthesis in the commitment to replication in hepatoma 3924A cells, Cancer Res., 48, 507
Weber, 1981, Dynamics of modulation of biochemical programs in cancer cells, Adv. Enzyme Regul., 19, 87, 10.1016/0065-2571(81)90010-8
Tricot, 1987, Hematological and biochemical action of tiazofurin (NSC 286193) in a case of refractory acute myeloid leukemia, Cancer Res., 47, 4988
Weber, 1976, Key enzymes of IMP metabolism: transformation- and progression-linked alterations in gene expression, Adv. Enzyme Regul., 14, 3, 10.1016/0065-2571(76)90005-4
Weber, 1977, Enzymology of cancer cells, New England J. Med., 296, 486, 10.1056/NEJM197703032960905
Weber, 1977, Enzymology of cancer cells, New England J. Med., 296, 541, 10.1056/NEJM197703102961005
Robins, 1982, Nucleoside and nucleotide inhibitors of inosine monophosphate (IMP) dehydrogenase as potential antitumor inhibitors, Nucleosides Nucleotides, 1, 35, 10.1080/07328318208079400
Srivastava, 1977, Synthesis and antiviral activity of certain thiazole C-nucleosides, J. Med. Chem., 20, 256, 10.1021/jm00212a014
Robins, 1982, 2-β-d-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases, J. Med. Chem., 25, 107, 10.1021/jm00344a002
Jayaram, 1982, Initial studies on the mechanisms of action of a new oncolytic thiazole nucleoside, 31, 2371
Jayaram, 1984, Biochemical mechanisms of resistance to tiazofurin, Adv. Enzyme Regul., 24, 67, 10.1016/0065-2571(85)90070-6
Cooney, 1982, The conversion of 2-β-d-ribofuranosylthiazole-4-carboxamide to an analog of NAD with potent IMP dehydrogenase-inhibitory properties, Biochem. Pharmacol., 31, 2133, 10.1016/0006-2952(82)90436-1
Kuttan, 1982, Inhibition of inosinate dehydrogenase by metabolites of 2-β-d-ribofuranosylthiazole-4-carboxamide, Biochem. Biophys. Res. Commun., 107, 862, 10.1016/0006-291X(82)90602-7
O'Dwyer, 1988
Lui, 1984, Modulation of IMP dehydrogenase activity and guanylate metabolism by tiazofurin, J. Biol. Chem., 259, 5078, 10.1016/S0021-9258(17)42958-9
Weber, 1984, Control of enzymic programs and nucleotide pattern in cancer cells by activicin and tiazofurin, Adv. Enzyme Regul., 22, 69, 10.1016/0065-2571(84)90009-8
Cooney, 1983, Studies on the mechanism of action of tiazofurin metabolism to an analog of NAD with potent IMP dehydrogenase-inhibitory activity, Adv. Enzyme Regul., 21, 271, 10.1016/0065-2571(83)90019-5
Jayaram, 1986, Selective sensitivity to tiazofurin of human leukemic cells, 27, 385
Jayaram, 1988, Biochemistry of a predictive test to select leukemic patients sensitive to tiazofurin treatment, 29
Yamada, 1988, Action of active metabolites of tiazofurin and ribavirin on purified IMP dehydrogenase, Biochemistry, 10.1021/bi00406a057
Yoshida, 1980, Antitumor activities of newly synthesized 5-carbamoyl-1-H-imidazol-4yl l-adamantanecarboxylate and 5-carbamoyl-1-H-imidazol-4yl piperonylate, Cancer Res., 40, 3810
Jackson, 1977, Partial purification, properties and regulation of inosine 5′-phosphate dehydrogenase in normal and malignant rat tissues, Biochem. J., 166, 1, 10.1042/bj1660001
Weber, 1985, Regulation of purine and pyrimidine metabolism by insulin and by resistance to tiazofurin, Adv. Enzyme Regul., 23, 81, 10.1016/0065-2571(85)90041-X
Jayaram, 1986, Mechanism of resistance to tiazofurin in hepatoma 3924A, Biochem. Pharmacol., 35, 587, 10.1016/0006-2952(86)90352-7
Jayaram, 1986, Selective sensitivity to tiazofurin of human leukemic cells, Biochem. Pharmacol., 35, 2029, 10.1016/0006-2952(86)90737-9
Jayaram, 1986, Increased nucleoside concentrations in tumors as markers of tiazofurin action, Nucleosides Nucleotides, 5, 503, 10.1080/07328318608068692
Simmonds, 1981, High-performance liquid chromatographic methods for base and nucleoside analysis in extracellular fluids and in cells, J. Chromatogr., 226, 369, 10.1016/S0378-4347(00)86071-5
Levya, 1980, High performance liquid chromatography of plasma pyrimidines and purines and its application in cancer chemotherapy, Adv. Exp. Med. Biol., 122B, 389, 10.1007/978-1-4684-8559-2_62
Robins, 1956, Potential purine antagonists, 78, 784
Lucas, 1983, Purine metabolism in myeloid precursor cells during maturation, J. Clin. Invest., 72, 1889, 10.1172/JCI111152
Lucas, 1983, Induced maturation of the human promyelocytic leukemia cell, 115, 971
Wright, 1987, A role for guanine ribonucleotides in the regulation of myeloid cell maturation, Blood, 69, 334, 10.1182/blood.V69.1.334.334
Sokoloski, 1986, Alterations in glycoprotein synthesis and guanosine triphosphate levels associated with the differentiation of HL-60 leukemia cells produced by inhibitors of inosine 5′-phosphate dehydrogenase, Cancer Res., 46, 2314
Sokoloski, 1987, Inhibition of the synthesis of glycoproteins and induction of the differentiation of HL-60 promyelocytic leukemia cells by 6-methylmercaptopurine ribonucleoside, Cancer Res., 47, 6283
Dixon, 1979, 354
Olah, 1988